お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:世界の薬剤溶出ステントの市場
市場調査レポート
商品コード
969286

世界の薬剤溶出ステントの市場

Global Drug-Eluting Stents Market

出版日: | 発行: BCC Research | ページ情報: 英文 127 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.81円
世界の薬剤溶出ステントの市場
出版日: 2020年11月04日
発行: BCC Research
ページ情報: 英文 127 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の薬剤溶出ステントの市場規模は、2019年の67億米ドルから、2024年には93億米ドルへと、6.8%のCAGRで成長する、と予測されています。

当レポートでは、世界の薬剤溶出ステントの市場について分析し、製品・技術の概要や市場の基本構造、主な市場促進・抑制要因、市場規模・成長率・市場シェアの動向見通し (過去2年間・今後5年間分)、地域別・製品別・用途別・エンドユーザー別の詳細動向、規制制定・技術開発の動き、主要企業のプロファイル、新型コロナウイルス感染症 (Covid-19) による影響、といった情報を取りまとめてお届けいたします。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 医療機器の規制

  • 医療機器の定義と分類
  • 世界各国の規制 (米国・欧州・日本)

第4章 薬剤溶出ステント:パイプライン分析

  • 概要

第5章 薬剤溶出ステント:市場の背景事情

  • イントロダクション
  • 市場の沿革
  • コーティングとポリマー
  • DESで使用される薬剤
  • 心血管疾患(CVD)
  • CVDの一般的な種類
  • CVDの症状
  • CVDの危険因子
  • CVDの治療方法

第6章 薬剤溶出ステント:市場力学

  • 市場力学
  • 市場促進要因
  • 市場抑制要因

第7章 新型コロナウイルス感染症 (COVID-19) 感染拡大の影響

  • イントロダクション
  • アウトブレイク
  • COVID-19の症状
  • COVID-19の進行
  • 潜伏期間
  • 疫学
  • 世界各地のCOVID-19の確認された発症者数・死亡者数
  • 各種組織と政府のコラボレーション
  • 疾患の蔓延状況
  • 現在の状況と医療系IT企業 (MedTech) への影響
  • 待機手術 (選択的/重要ではない手順)
  • 製造業のシフト
  • 規制の遅れ、治験、製品上市
  • サプライチェーンの混乱
  • メディカルツーリズム

第8章 製品別の市場区分

  • 世界の薬剤溶出ステント市場:製品別
  • ポリマーベース薬剤溶出ステント
    • 市場規模と予測
    • 市場分析
  • ポリマーフリー薬剤溶出ステント

第9章 用途別の市場区分

  • 世界の薬剤溶出ステント市場:用途別
  • 冠状動脈疾患(CAD)
  • 末梢動脈疾患(PAD)

第10章 エンドユーザー別の市場区分

  • 世界の薬剤溶出ステント市場:エンドユーザー別
  • 病院
  • 外来手術センター
  • 専門センター・クリニック

第11章 地域別の市場区分

  • 世界の薬剤溶出ステント市場:地域別
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第12章 競合情勢

  • 世界の企業シェア分析
  • 企業合併・買収 (M&A)
  • 合意、事業提携・協力、製品上市

第13章 企業プロファイル

  • ABBOTT
  • ALVIMEDICA
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL INC.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONIC PLC
  • TERUMO CORP.

第14章 付録:頭字語一覧

図表

List of Tables

  • Summary Table A: Global Market for Drug-Eluting Stents, by Product, Through 2024
  • Summary Table C: Global Market for Drug-Eluting Stents, by End User, Through 2024
  • Summary Table B: Global Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 1: Class I and II Exempt Devices
    • Table 2: Selected Clinical Trial Studies: Drug-Eluting Stents
    • Table 3: Selected Coronary Stents
    • Table 4: Drugs Commonly Used in DES
    • Table 5: CVD Risk Factors
    • Table 6: Coronary Angioplasty Procedures, by Country, 2018
    • Table 7: Distribution of COVID-19 Symptoms
    • Table 8: COVID-19: Confirmed Cases and Deaths, by Country, as of Aug. 3, 2020
    • Table 9: Global Market for Drug-Eluting Stents, by Product Segment, Through 2024
    • Table 10: Common Polymers Used in DES
    • Table 11: Coating Methods to Develop Polymer-Free Drug-Eluting Stents
    • Table 12: Global Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 13: Global Market for Drug-Eluting Stents, by End User, Through 2024
    • Table 14: Global Market for Drug-Eluting Stents, by Region, Through 2024
    • Table 15: North American Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 16: Estimated Number of U.S. Stent Procedures, by Type of Procedure, 2014
    • Table 17: European Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 18: Asia-Pacific Market for Drug-Eluting Stents, by Country, Through 2024
    • Table 19: Latin American Market for Drug-Eluting Stents, by Product, Through 2024
    • Table 20: Latin American Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 21: Latin American Market for Drug-Eluting Stents, by End User, Through 2024
    • Table 22: Leading Causes of Death and Percentage Change in Argentina, 2007-2017
    • Table 23: Middle Eastern and African Market for Drug-Eluting Stents, by Product, Through 2024
    • Table 24: Middle Eastern and African Market for Drug-Eluting Stents, by Application, Through 2024
    • Table 25: Middle Eastern and African Market for Drug-Eluting Stent, by End User, Through 2024
    • Table 26: Global Market Shares of Drug-Eluting Stents, by Company, 2019
    • Table 27: Abbott: Drug-Eluting Stents, Product Portfolio
    • Table 28: Alvimedica: Drug-Eluting Stents, Product Portfolio
    • Table 29: B. Braun Melsungen AG: Drug-Eluting Stents, Product Portfolio
    • Table 30: Biosensors International: Drug-Eluting Stents, Product Portfolio
    • Table 31: Biotronik SE & Co. KG: Drug-Eluting Stents, Product Portfolio
    • Table 32: Boston Scientific Corp.: Drug-Eluting Stents, Product Portfolio
    • Table 33: Cook Medical Inc.: Drug-Eluting Stents, Product Portfolio
    • Table 34: Lepu Medical Technology (Beijing) Co., Ltd.: Drug-Eluting Stents, Product Portfolio
    • Table 35: Medtronic Plc: Drug-Eluting Stents, Product Portfolio
    • Table 36: Terumo Corp.: Drug-Eluting Stents, Product Portfolio
    • Table 37: Acronyms Used in the Drug-Eluting Stents Industry

List of Figures

  • Summary Figure C: Global Market for Drug-Eluting Stents, by Application, 2018-2024
  • Summary Figure B: Global Market Shares of Drug-Eluting Stents, by Product, 2019
  • Summary Figure A: Global Market for Drug-Eluting Stents, by Product, 2018-2024
  • Summary Figure D: Global Market Shares of Drug-Eluting Stents, by Application, 2019
  • Summary Figure E: Global Market for Drug-Eluting Stents, by End User, 2018-2024
  • Summary Figure F: Global Market Shares of Drug-Eluting Stents, by End User, 2019
    • Figure 1: Marketing a Medical Device in the U.S.
    • Figure 2: Historical Milestones: Coronary Artery Stenting
    • Figure 3: Global Disease Burden, 2017
    • Figure 4: Adults with Cardiovascular Conditions, by Country, 2019
    • Figure 5: Top 10 Global Causes of Deaths, 2016
    • Figure 6: Global Geriatric Population (Aged 65+ Years), 2014-2022
    • Figure 7: Surgical Operations Performed Globally, 2004 and 2012
    • Figure 8: Global Market Shares of Drug-Eluting Stents, by Product Segment, 2019
    • Figure 9: Global Market for Polymer-Based Drug-Eluting Stents, 2018-2024
    • Figure 10: Global Market for Polymer-Based Drug-Eluting Stents, by Region, 2018-2024
    • Figure 11: Global Market for Polymer-Free Drug-Eluting Stents, 2018-2024
    • Figure 12: Global Market for Polymer-Free Drug-Eluting Stents, by Region, 2018-2024
    • Figure 13: Global Market Shares of Drug-Eluting Stents, by Application, 2019
    • Figure 14: Global Market for Coronary Artery Disease, 2018-2024
    • Figure 15: Global Market for Peripheral Artery Disease, 2018-2024
    • Figure 16: Global Market Shares of Drug-Eluting Stents, by End User, 2019
    • Figure 17: Global Market for Drug-Eluting Stents in Hospital End Use, 2018-2024
    • Figure 18: Global Market for Drug-Eluting Stents in Ambulatory Surgical Center End Use, 2018-2024
    • Figure 19: Global Market for Drug-Eluting Stents in Specialty Center and Clinic End Use, 2018-2024
    • Figure 20: Global Market Shares of Drug-Eluting Stents, by Region, 2019
    • Figure 21: North American Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 22: U.S. Market for Drug-Eluting Stents, 2018-2024
    • Figure 23: U.S. Population Aged 65+, Projection and Trends, 2010-2050
    • Figure 24: Distribution of Deaths in the U.S. from CVD, by Disease Sub-Segment, 2016
    • Figure 25: Canadian Market for Drug-Eluting Stents, 2018-2024
    • Figure 26: European Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 27: German Market for Drug-Eluting Stents, 2018-2024
    • Figure 28: U.K. Market for Drug-Eluting Stents, 2018-2024
    • Figure 29: French Market for Drug-Eluting Stents, 2018-2024
    • Figure 30: Italian Market for Drug-Eluting Stents, 2018-2024
    • Figure 31: Spanish Market for Drug-Eluting Stents, 2018-2024
    • Figure 32: Rest of European Market for Drug-Eluting Stents, 2018-2024
    • Figure 33: Asia-Pacific Market Shares of Drug-Eluting Stents, by Country, 2019
    • Figure 34: Japanese Market for Drug-Eluting Stents, 2018-2024
    • Figure 35: Chinese Market for Drug-Eluting Stents, 2018-2024
    • Figure 36: Shares of Major Causes of Death in Rural China, 2016
    • Figure 37: Shares of Major Causes of Death in Urban China, 2016
    • Figure 38: Indian Market for Drug-Eluting Stents, 2018-2024
    • Figure 39: Rest of Asia-Pacific Market for Drug-Eluting Stents, 2018-2024
    • Figure 40: Latin American Market for Drug-Eluting Stents, 2018-2024
    • Figure 41: Latin American Market Shares of Drug-Eluting Stents, by Product, 2019
    • Figure 42: Middle Eastern and African Market for Drug-Eluting Stents, 2018-2024
    • Figure 43: Middle Eastern and African Market Shares of Drug-Eluting Stents, by Product, 2019
    • Figure 44: Abbott: Annual Revenue, 2017-2019
    • Figure 45: Abbott: Revenue Share, by Country, 2019
    • Figure 46: Abbott: Revenue Share, by Product Category, 2019
    • Figure 47: B. Braun Melsungen AG: Annual Revenue, 2017-2019
    • Figure 48: B. Braun Melsungen AG: Revenue Share, by Business Division, 2019
    • Figure 49: B. Braun Melsungen AG: Revenue Share, by Country/Region, 2019
    • Figure 50: Boston Scientific Corp.: Annual Revenue, 2017-2019
    • Figure 51: Boston Scientific Corp.: Revenue Share, by Product Category, 2019
    • Figure 52: Boston Scientific Corp.: R&D Expenditures, 2017-2019
    • Figure 53: Lepu Medical Technology (Beijing) Co., Ltd.: Annual Revenue, 2017-2019
    • Figure 54: Medtronic Plc: Annual Revenue, 2017-2019
    • Figure 55: Medtronic Plc: Revenue Share, by Country/Region, 2019
    • Figure 56: Medtronic Plc: Revenue Share, by Product Category, 2019
    • Figure 57: Terumo Corp.: Annual Revenue, 2017-2019
    • Figure 58: Terumo Corp.: Revenue Share, by Product Category, 2019
目次
Product Code: MDS026A

Highlights:

The global market for drug-eluting stents should grow from $6.7 billion in 2019 to $9.3 billion by 2024 at a compound annual growth rate (CAGR) of 6.8% during the period of 2019-2024.

The global market for polymer-based drug-eluting stents should grow from $4.1 billion in 2019 to $5.4 billion by 2024 at a CAGR of 6.0% during the period of 2019-2024.

The global market for polymer-free drug-eluting stents should grow from $2.7 billion in 2019 to $3.9 billion by 2024 at a CAGR of 7.9% during the period of 2019-2024.

Report Scope:

This report examines the current and projected market potential of drug-eluting stents. It offers a detailed analysis of the regulatory scenario, competitive environment, pipeline, technological advancement, drivers, restraints and market growth trends. The report also includes market projections through 2024 and the market rank for key market players. The report details the market share of drug-eluting stents based on types of product, application and end user.

By product type, the market is segmented into polymer-based drug-eluting stents and polymer-free drug-eluting stents. By application, the market is segmented into coronary artery disease (CAD) and peripheral artery disease (PAD). By end user, the market is segmented into hospitals, ambulatory surgical centers and specialty centers and clinics.

By geography, the market is segmented into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2018 as the base year, 2019 and forecast through year-end 2024. Estimated values used are based on drug-eluting stent manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

  • 20 data tables and 18 additional tables
  • An overview of global market for drug-eluting stents within the medical devices industry
  • Estimation of the market size and analyses of market trends, with data from 2018 and 2019, and projections of compound annual growth rates (CAGRs) through 2024
  • Market share analysis of the drug-eluting stents based on product, application, end-use, and region
  • Identification of segments with high growth potential and analysis of future applications of each of the segments
  • Assessment of market dynamics for drug-eluting stents with market drivers and restraints explained, medical device regulations, market background and pipeline analysis of the stents
  • Coverage of prevalence and epidemiology of cardiovascular disease and description of coronary artery disease (CAD) and peripheral artery disease (PAD)
  • Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
  • Company profiles of the leading market players, including Abbott, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp., Medtronic Plc and Cook Medical Inc.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Market Highlights: Drug-Eluting Stents

Chapter 3: Medical Device Regulations

  • Medical Device Definition and Classification
  • Regulations in the U.S.
  • Code of Federal Regulations
  • Regulations in Europe
  • Regulations in Japan

Chapter 4: Drug-Eluting Stents: Pipeline Analysis

  • Overview

Chapter 5: Drug-Eluting Stents: Market Background

  • Introduction
  • Market Evolution
  • Coating and Polymers
  • Drugs Used in DESs
  • Cardiovascular Diseases (CVDs)
  • Common Types of CVD
  • Symptoms of CVD
  • Risk Factors: CVD
  • Treatment for CVD

Chapter 6: Drug-Eluting Stents: Market Dynamics

  • Market Dynamics
  • Market Drivers
  • Market Restraints

Chapter 7: Impact of COVID-19 Pandemic

  • Introduction
  • Outbreak
  • Symptoms of COVID-19
  • Progression of COVID-19
  • Incubation Period
  • Epidemiology
  • Global Confirmed COVID-19 Cases and Deaths
  • Collaboration Between Organizations and Governments
  • Spread of Disease
  • Current Status and Impact on MedTech
  • Elective and Noncritical Procedures
  • Shift in Manufacturing
  • Regulatory Delays, Clinical Trials and Product Launches
  • Supply Chain Disruptions
  • Medical Tourism

Chapter 8: Market Breakdown, by Product

  • Global Market for Drug-Eluting Stents, by Product
  • Polymer-Based Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis
  • Polymer-Free Drug-Eluting Stents
  • Market Size and Forecast
  • Market Analysis

Chapter 9: Market Breakdown, by Application

  • Global Market for Drug-Eluting Stents, by Application
  • Coronary Artery Disease (CAD)
  • Market Size and Forecast
  • Market Analysis
  • Peripheral Artery Disease (PAD)
  • Market Size and Forecast
  • Market Analysis

Chapter 10: Market Breakdown, by End User

  • Global Market for Drug-Eluting Stents, by End User
  • Hospitals
  • Market Size and Forecast
  • Market Analysis
  • Ambulatory Surgical Centers
  • Market Size and Forecast
  • Market Analysis
  • Specialty Centers and Clinics
  • Market Size and Forecast
  • Market Analysis

Chapter 11: Market Breakdown, by Region

  • Global Market for Drug-Eluting Stents, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • Latin America
  • Middle East and Africa

Chapter 12: Competitive Landscape

  • Global Company Share Analysis
  • Mergers and Acquisitions
  • Agreements, Collaborations, Product Launches and Partnerships

Chapter 13: Company Profiles

  • ABBOTT
  • ALVIMEDICA
  • B. BRAUN MELSUNGEN AG
  • BIOSENSORS INTERNATIONAL
  • BIOTRONIK SE & CO. KG
  • BOSTON SCIENTIFIC CORP.
  • COOK MEDICAL INC.
  • LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
  • MEDTRONIC PLC
  • TERUMO CORP.

Chapter 14: Appendix: List of Acronyms

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.